Fundraising Fox
Watchmaker Genomics
Boulder, US · Founded 2018 · Delaware corporation · 277 employees on LinkedIn · 2 known investors
Find your way into Watchmaker Genomics
Sign up to see every warm intro you have to Watchmaker Genomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Watchmaker Genomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Watchmaker Genomics develops and manufactures purpose-designed enzymes, reagents, and workflows for molecular biology and genomics applications, including inherited disease, somatic oncology, transcriptomics, and epigenomics research. It operates as an OEM supplier serving genomics technology developers and high-throughput sequencing labs.
Founders & leadership
Watchmaker Genomics was founded in 2018 by John Foskett.
Investors · 2
How we know: Decheng Capital's portfolio page · funding news · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$48.3M disclosed across 2 rounds · 2020–2022
▶$40MraisedJun 2022 · 2 investors · OtherRule 506(b)
- Stephen PiconeExecutive Officer, Director, Promoter
- Brian KudlowExecutive Officer, Director, Promoter
- Brian DeneauExecutive Officer
- Paul McEwanDirector, Promoter
- Victor TongDirector
- John FoskettExecutive Officer, Director, Promoter
- Offering amount
- $40M
- Amount sold
- $40M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$8.3MraisedDec 2020 · 27 investors · OtherRule 506(b)
- Paul McEwanDirector, Promoter
- Christopher McGuinnessDirector
- John FoskettExecutive Officer, Director, Promoter
- Brian DeneauExecutive Officer, Director
- Stephen PiconeExecutive Officer, Director, Promoter
- Brian KudlowExecutive Officer, Director, Promoter
- Offering amount
- $8.3M
- Amount sold
- $8.3M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Watchmaker Genomics do?
- Watchmaker Genomics develops and manufactures purpose-designed enzymes, reagents, and workflows for molecular biology and genomics applications, including inherited disease, somatic oncology, transcriptomics, and epigenomics research. It operates as an OEM supplier serving genomics technology developers and high-throughput sequencing labs.
- Who founded Watchmaker Genomics?
- Watchmaker Genomics was founded by John Foskett in 2018.
- Who are Watchmaker Genomics's investors?
- Watchmaker Genomics's investors include Decheng Capital, Eclipse Ventures.
- How much funding has Watchmaker Genomics raised?
- Watchmaker Genomics has disclosed $48.3M raised across 2 rounds.
- Where is Watchmaker Genomics headquartered?
- Watchmaker Genomics is headquartered in Boulder, US.